Axelyf
Latest round
- Seed
Last raised
- Jul 2025
Total raised
- $4.8M
Investors
- 3
About Axelyf
Founded in 2022 in Brookline, US, Axelyf, Inc. develops RNA medicine technologies. The company’s founder has prior experience in biotechnology ventures. In July 2025, Axelyf, Inc. Axelyf specializes in RNA medicines, offering proprietary lipid technology named AXL, which optimizes gene editing and reduces toxicity. Their revenue model is based on collaborations with biotech firms and pharmaceutical companies, focusing on milestone payments and royalties related to their AXL technology.84 mn, Axelyf plans to advance its AXL technology and enhance RNA delivery using artificial intelligence. The company is targeting expansion into new markets, specifically within the biopharmaceutical sectors of North America and Europe, by 2025.
Who invested in Axelyf
3 investors across 1 round
See all investors in Axelyf
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
Jul 25, 2025
Amount
$4.8M
Investors
Questions about Axelyf
Who invested in Axelyf?
Axelyf has 3 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Axelyf raised?
Axelyf has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Axelyf last raise money?
Axelyf's most recent round on record is a Seed, in Jul 2025.
What does Axelyf do?
Founded in 2022 in Brookline, US, Axelyf, Inc.
Where is Axelyf headquartered?
Axelyf is headquartered in Brookline, US.
Which VCs invest in companies like Axelyf?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Axelyf's stage. Their profiles are linked below.
VCs backing biotechnology startups at Seed
Raising like Axelyf? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.